When there is precancerous or aberrant cell proliferation in or around the cervix, it is called Cervical Dysplasia. If detected too late, the presence could result in cervical cancer. Cervical dysplasia has several main causes, one of which is the Human Papillomavirus (HPV). One of the main drivers of the cervical dysplasia market is the increase in government-funded cancer screening programmes. For instance, the first government campaign to raise awareness of cervical dysplasia screening using smear tests was introduced by Public Health England in March 2019. According to the same source, due to the stigma and fear surrounding the Pap test, the percentage of women aged 25 and older who get smear tests is currently at its lowest point in two decades.
Over the forecast period, the high prevalence of cervical cancer is anticipated to fuel expansion for Global Cervical Dysplasia Market. For instance, cervical cancer, with an anticipated 570,000 new cases in 2018 and 6.6% of all female cancers, is the fourth most common cancer in women, according to the World Health Organization. Additionally, an increase in smokers is anticipated to fuel the expansion of the worldwide cervical dysplasia market. For instance, 1.337 billion individuals globally smoked tobacco in 2018, according to the World Health Organization.
Read More- https://cmi-latestreportorientedblogs.blogspot.com/2023/01/global-cervical-dysplasia-market-is.html
